Bristol Myers Stock Options Expiring on 16th of May
| BMY Stock | USD 58.90 0.31 0.52% |
Bristol Myers' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 0.5 with a put-to-call open interest ratio of 0.63 over 42 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 704, with calls trading at the volume of 711. This yields a 0.99 put-to-call volume ratio.
Open Interest Against May 16th 2025 Option Contracts
Bristol Myers option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Bristol Myers' lending market. For example, when Bristol Myers' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Bristol Myers, he or she must hedge the risk by shorting Bristol Myers stock over its option's life.
2025-05-16
The chart above shows Bristol Myers' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bristol Myers' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bristol Myers' option, there is no secondary market available for investors to trade.
Bristol Myers Maximum Pain Price Across 2025-05-16 Option Contracts
Max pain occurs when Bristol Myers' market makers reach a net positive position across all Bristol Myers' options at a strike price where option holders stand to lose the most money. By contrast, Bristol Myers' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Bristol Myers Squibb In The Money Call Balance
When Bristol Myers' strike price is surpassing the current stock price, the option contract against Bristol Myers Squibb stock is said to be in the money. When it comes to buying Bristol Myers' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Bristol Myers Squibb are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Bristol Current Options Market Mood
Bristol Myers' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bristol Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Bristol Myers' options investors are not very successful. Bristol Myers' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Bristol contract
Base on the Rule 16, the options market is currently suggesting that Bristol Myers Squibb will have an average daily up or down price movement of about 0.0313% per day over the life of the 2025-05-16 option contract. With Bristol Myers trading at USD 58.9, that is roughly USD 0.0184. If you think that the market is fully incorporating Bristol Myers' daily price movement you should consider buying Bristol Myers Squibb options at the current volatility level of 0.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Bristol |
Bristol Myers Option Chain
When Bristol Myers' strike price is surpassing the current stock price, the option contract against Bristol Myers Squibb stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bristol Myers' option chain is a display of a range of information that helps investors for ways to trade options on Bristol. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bristol. It also shows strike prices and maturity days for a Bristol Myers against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | BMY250516C00085000 | 0 | 85.0 | 0.0 - 0.47 | 0.47 | |
Call | BMY250516C00080000 | 696 | 80.0 | 0.0 - 0.1 | 0.08 | Out |
Call | BMY250516C00075000 | 928 | 75.0 | 0.05 - 0.21 | 0.05 | Out |
Call | BMY250516C00070000 | 2455 | 70.0 | 0.13 - 0.16 | 0.15 | Out |
Call | BMY250516C00067500 | 11752 | 67.5 | 0.28 - 0.32 | 0.29 | Out |
Call | BMY250516C00065000 | 13307 | 65.0 | 0.6 - 0.63 | 0.61 | Out |
Call | BMY250516C00062500 | 15646 | 62.5 | 1.16 - 1.2 | 1.2 | Out |
Call | BMY250516C00060000 | 13761 | 60.0 | 2.06 - 2.12 | 2.1 | Out |
Call | BMY250516C00057500 | 2937 | 57.5 | 3.3 - 3.4 | 3.35 | In |
Call | BMY250516C00055000 | 2881 | 55.0 | 4.95 - 5.05 | 5.15 | In |
Call | BMY250516C00052500 | 3120 | 52.5 | 6.85 - 7.0 | 7.26 | In |
Call | BMY250516C00050000 | 1139 | 50.0 | 9.05 - 9.2 | 9.1 | In |
Call | BMY250516C00047000 | 443 | 47.0 | 11.9 - 12.05 | 12.3 | In |
Call | BMY250516C00045000 | 642 | 45.0 | 13.85 - 14.05 | 16.2 | In |
Call | BMY250516C00043000 | 1657 | 43.0 | 15.85 - 16.05 | 16.12 | In |
Call | BMY250516C00040000 | 382 | 40.0 | 18.85 - 19.0 | 19.2 | In |
Call | BMY250516C00038000 | 28 | 38.0 | 19.95 - 21.05 | 16.55 | In |
Call | BMY250516C00035000 | 17 | 35.0 | 23.85 - 24.05 | 24.5 | In |
Call | BMY250516C00030000 | 15 | 30.0 | 28.1 - 30.05 | 26.47 | In |
Call | BMY250516C00025000 | 10 | 25.0 | 32.55 - 35.55 | 30.54 | In |
Put | BMY250516P00085000 | 0 | 85.0 | 26.3 - 26.8 | 26.3 | In |
Put | BMY250516P00080000 | 0 | 80.0 | 21.55 - 21.7 | 22.05 | In |
Put | BMY250516P00075000 | 0 | 75.0 | 15.95 - 16.75 | 17.85 | In |
Put | BMY250516P00070000 | 2 | 70.0 | 11.55 - 11.75 | 11.64 | In |
Put | BMY250516P00067500 | 262 | 67.5 | 9.15 - 9.35 | 7.4 | In |
Put | BMY250516P00065000 | 649 | 65.0 | 6.95 - 7.1 | 6.0 | In |
Put | BMY250516P00062500 | 1048 | 62.5 | 5.0 - 5.1 | 3.7 | In |
Put | BMY250516P00060000 | 4548 | 60.0 | 3.4 - 3.5 | 3.35 | In |
Put | BMY250516P00057500 | 12497 | 57.5 | 2.1 - 2.27 | 2.15 | Out |
Put | BMY250516P00055000 | 10281 | 55.0 | 1.21 - 1.39 | 1.35 | Out |
Put | BMY250516P00052500 | 1596 | 52.5 | 0.78 - 0.82 | 0.79 | Out |
Put | BMY250516P00050000 | 2121 | 50.0 | 0.43 - 0.48 | 0.45 | Out |
Put | BMY250516P00047000 | 1365 | 47.0 | 0.21 - 0.25 | 0.23 | Out |
Put | BMY250516P00045000 | 690 | 45.0 | 0.05 - 0.21 | 0.09 | Out |
Put | BMY250516P00043000 | 1759 | 43.0 | 0.03 - 0.35 | 0.14 | Out |
Put | BMY250516P00040000 | 2429 | 40.0 | 0.02 - 0.31 | 0.17 | Out |
Put | BMY250516P00038000 | 1521 | 38.0 | 0.01 - 0.19 | 0.12 | Out |
Put | BMY250516P00035000 | 1634 | 35.0 | 0.0 - 0.48 | 0.09 | Out |
Put | BMY250516P00033000 | 1862 | 33.0 | 0.0 - 0.16 | 0.04 | Out |
Put | BMY250516P00030000 | 235 | 30.0 | 0.0 - 0.2 | 0.08 | Out |
Put | BMY250516P00028000 | 106 | 28.0 | 0.0 - 0.08 | 0.02 | Out |
Put | BMY250516P00025000 | 783 | 25.0 | 0.0 - 0.02 | 0.03 | Out |
Bristol Myers Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Bristol Myers Market Cap Over Time
Market Cap |
| Timeline |
Bristol Total Stockholder Equity
Total Stockholder Equity |
|
Bristol Myers Corporate Directors
| Karen Vousden | Independent Director | Profile | |
| Michael Bonney | Independent Director | Profile | |
| Robert Bertolini | Independent Director | Profile | |
| Gerald Storch | Independent Director | Profile |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.